MeiraGTx Holdings (MGTX) Accumulated Expenses (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Accumulated Expenses of $3.9 million for Q4 2025, up 73.1% on a YoY basis from $2.2 million in Q4 2024, and up 40.77% quarter-over-quarter from $2.7 million in Q3 2025.
MeiraGTx Holdings (MGTX) Accumulated Expenses (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Accumulated Expenses for 9 years, with the latest figure at $3.9 million in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Expenses rose 73.1% year-over-year to $3.9 million; the trailing twelve-month figure through Dec 2025 stood at $3.9 million (up 73.1% YoY), and the FY2025 full-year result was $3.9 million, up 73.1% from the prior year.
- Accumulated Expenses for Q4 2025 stood at $3.9 million, up from $2.7 million in the prior quarter.
- The five-year high for Accumulated Expenses was $31.1 million in Q1 2023, with the low at $726000.0 in Q2 2022.
- Historically, Accumulated Expenses has averaged $10.8 million across 5 years, with a median of $3.9 million in 2024.
- Annual changes were most pronounced in 2022 — Accumulated Expenses slumped 95.1% — and 2023, when it surged 3576.57%.
- MeiraGTx Holdings' Accumulated Expenses stood at $27.6 million in 2021, then slumped by 52.73% to $13.0 million in 2022, then plunged by 77.49% to $2.9 million in 2023, then dropped by 23.91% to $2.2 million in 2024, then surged by 73.1% to $3.9 million in 2025.
- The last three Accumulated Expenses figures came in at $3.9 million (Q4 2025), $2.7 million (Q3 2025), and $15.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.87 Mn |
| Sep 30, 2025 | 2.75 Mn |
| Jun 30, 2025 | 15.48 Mn |
| Mar 31, 2025 | 2.62 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 3.84 Mn |
| Jun 30, 2024 | 16.93 Mn |
| Mar 31, 2024 | 17.35 Mn |
| Dec 31, 2023 | 2.94 Mn |
| Sep 30, 2023 | 28.25 Mn |
| Jun 30, 2023 | 24.89 Mn |
| Mar 31, 2023 | 31.07 Mn |
| Dec 31, 2022 | 13.04 Mn |
| Sep 30, 2022 | 1.12 Mn |
| Jun 30, 2022 | 726,000.00 |
| Mar 31, 2022 | 845,000.00 |
| Dec 31, 2021 | 27.59 Mn |
| Sep 30, 2021 | 1.81 Mn |
| Jun 30, 2021 | 1.43 Mn |
| Mar 31, 2021 | 17.25 Mn |